Merabutin Tablets (Trimebutine Maleate)

Adult dose

Adults: Administer 100-200 mg of Trimebutine Maleate orally 3 times a day before meals. Adjust dosage appropriately based on age and symptoms.

This medication may affect the gastrointestinal system and can rarely cause symptoms such as constipation or diarrhea, audible gas in the intestines, nausea, vomiting, dyspepsia, dry mouth, or a feeling of numbness in the mouth. Additionally, cardiovascular symptoms such as palpitations may occur rarely. It can also impact the nervous system, leading to fatigue, drowsiness, dizziness, lethargy, and headaches, which are rare side effects. There are rare reports of elevated liver enzyme levels, indicating potential liver function impact. Rash or other hypersensitivity reactions may occur, although infrequently, and if such symptoms appear, the use of this medication should be discontinued. The safety of this medication during pregnancy is not well established, so women who are pregnant or may become pregnant should use it only if the benefits outweigh the risks. Safety during breastfeeding has also not been confirmed, so it is advisable to avoid it whenever possible, and if necessary, to discontinue breastfeeding.

Mild side effects

• Constipation
• diarrhea
• abdominal bloating
• nausea
• vomiting
• dyspepsia
• dry mouth
• feeling of oral numbness
• palpitations
• fatigue

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius (room temperature). Proper storage helps retain the medication's efficacy for an extended period.

Appearance

White round tablet

Package unit

PTP - 10 tablets/box [10 tablets/PTP*1], PTP - 20 tablets/box [10 tablets/PTP*2], PTP - 100 tablets/box [10 tablets/PTP*10], PTP - 240 tablets/box [(10 tablets/PTP*12)*2], Bottle - 100 tablets/bottle, Bottle - 500 tablets/bottle, Bottle - 1000 tablets/bottle